Request Trial
race-uphill-sand-dune
31 March 2014Kate Alzapiedi

Copyright compliance in the life sciences industry

Now that the rapid exchange of scientific research and product information across international borders has become commonplace, rights holders and users of published material face an increasingly complex set of issues involving reuse rights, permissions, restrictions and fees.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
To cite or not to cite: How can we avoid misuse of AI in court?
4 March 2026   With an increase in ‘hallucinated’ case law cited as evidence in courts globally, what can legal practitioners—as well as providers of AI tools and platforms—do to help safeguard against this? Sarah Speight finds out.
Careers
Gowling WLG brings in transactions expert with UK and US experience
3 March 2026   A former Pinsent Masons partner has joined the firm’s London office, boosting the team’s capabilities in high-value life sciences arrangements.
Europe
Emotional Perception: What next for patent holders?
3 March 2026   After an overwhelmingly positive Supreme Court ruling for companies working in AI, Rachel Free of CMS outlines the necessary practical steps for patent holders—including enforcement of the ‘black box’ tech, the ruling’s influence on the UPC, and how to manage related applications.


Editor's picks

LSPN Awards 2026 finalists revealed
Americas
LSPN Awards 2026 finalists revealed
2 March 2026

Editor's picks

Americas
LSPN Awards 2026 finalists revealed
2 March 2026
Americas
Eli Lilly escapes $278m payout in biotech licensing dispute
26 February 2026
Americas
Novo Nordisk takes on Hims & Hers after $49 pill ‘turnaround’
10 February 2026
Asia
AstraZeneca partners with Chinese firm ahead of next obesity race
5 February 2026
Americas
The quantum advantage: IP considerations for the next generation of life sciences innovation
27 January 2026
Europe
Final call: Who are the world’s best in-house counsel?
16 January 2026

More features

To cite or not to cite: How can we avoid misuse of AI in court?
Emotional Perception: What next for patent holders?
Nine-partner litigation team leaves Winston & Strawn
Firm adds seven-lawyer team in second major merger
Rooted in rights: Lessons from plant patent infringement and invalidity cases
Final call: Who are the world’s best in-house counsel?
How AI will be shaped by legal and regulatory developments in 2026
Bird & Bird targets Nordic life sciences growth with regulatory hire